Found: 8
Select item for more details and to access through your institution.
Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE).
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09055-z
- By:
- Publication type:
- Article
The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.868579
- By:
- Publication type:
- Article
CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1054, doi. 10.3390/cancers13051054
- By:
- Publication type:
- Article
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.561404
- By:
- Publication type:
- Article
Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Systematic reassessment of chemokine‐receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22.
- Published in:
- Journal of Leukocyte Biology, 2021, v. 109, n. 2, p. 373, doi. 10.1002/JLB.2AB0520-275R
- By:
- Publication type:
- Article
The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16664-0
- By:
- Publication type:
- Article